Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      New Causaly Work Helps Scientists Complete More of the Work Behind R&D Decisions, from Discovery Through Clinical Development

      This image opens in the lightbox

      News provided by

      Causaly

      12 Nov, 2026, 13:00 GMT

      Share this article

      Share this article


      Scientists set the objective, and Causaly Work plans the approach, runs the research and analysis, and delivers finished work the team can review, trust, and share

      LONDON, Nov. 12, 2026 /PRNewswire/ -- Before a life sciences R&D team can make a decision, scientists must find and weigh the evidence, analyze the data, compare the options, and prepare the reports, figures, and presentations the team needs. Causaly, the agentic AI platform for life sciences R&D, today introduced Causaly Work to help scientists from discovery through clinical development complete more of that work for their team's next decisions.

      This image opens in the lightbox
      Every scientific decision rests on work: data to analyze, evidence to weigh, a list to assess, a hypothesis to test. Meet Causaly Work. Set the objective and bring your question, with or without your own data. Specialized agents select the right methods, and you review the results, methods and evidence behind them. Your team steers the work and keeps the decision. Complete more scientific work for your team’s next decision.

      While Causaly's Agentic Research answers a question, Causaly Work pursues an objective. It pairs Causaly's scientific reasoning with a computational layer that produces a wide range of completed outputs. A scientist describes what they need to accomplish, such as ranking drug targets, building the case for a biomarker, or comparing past trials to inform a new study, and adds their own data or public sources. Scientists steer the work, challenge the results, and keep the decisions, while Causaly Work returns finished work the team can review.

      "High-stakes decisions in a development program depend on understanding every option, and the work to evaluate those options rarely follows a fixed script," said Yiannis Kiachopoulos, co-founder and CEO of Causaly. "Causaly Work adapts to the problem in front of it, so scientists can finally explore the paths they once set aside for lack of time. It widens the set of options and evaluates each one across the dimensions that matter, giving the people at the decision gate a fuller picture to judge from."

      Many promising paths in a development program go unexplored, not because they lack merit, but because exploring them takes more time than a team has. A single program decision can require searching the literature, analyzing internal and public datasets, working across specialist tools and systems, and turning the findings into reports, figures, and presentations.

      Every step and handoff takes time, so teams look at fewer options. General-purpose AI tools can speed up single steps, but they give an answer to trust, not work to check. Scientists can't see which methods were used, what was ruled out, or what evidence backs the result. That leaves researchers accountable for decisions they can't fully check.

      Purpose-built for life sciences, Causaly Work plans, carries out, and documents the work so the team can review every step:

      • Scientific planning before anything runs — A complex problem has many possible paths. Causaly Work first writes a plan that sets out the methods it chose and why, the alternatives it sets aside, the assumptions and evidence gaps, and the criteria for judging when the work is done.
      • Multiple agents that research methods and carry out the plan — Causaly Work directs specialized agents that research and validate the most appropriate methods, then coordinates them as they apply tools and scientific skills to complete each step.
      • Evidence and code the team can inspect — Code runs in a private workspace and stays open for review. Conclusions link back to the scientific literature and Causaly's biomedical knowledge graph, so reviewers see the evidence behind a result as well as the calculation that produced it.
      • Finished work products the team can share — Reports, ranked tables, figures, notebooks, slides, and interactive dashboards bring the rationale, caveats, and open questions together in one place the team can trust and pass along.

      Causaly Work joins Agentic Research and Scientific Workflows in the Causaly platform, and each fits a different kind of scientific work. Agentic Research answers a scientific question with cited evidence in minutes. Scientific Workflows run an approach that experts have codified into Causaly, giving teams a stable, governed process for standard operating procedures and other recurring work. Causaly Work takes on open-ended objectives, such as ideation and exploratory analysis, and selects the methods, rubric, and evaluation that fit each one. All three draw on the same scientific evidence base.

      To learn more about Causaly Work, visit https://www.causaly.com/products/causaly-work and register for our webinar at www.causaly.com/products/causaly-work.

      About Causaly
      Causaly is the agentic AI platform purpose-built for life sciences research and development. Powered by a high-precision biomedical knowledge graph and the world's scientific literature, Causaly enables specialized AI agents to automate scientific workflows and accelerate drug discovery and development with transparent, evidence-backed insights. Leading pharmaceutical and biotechnology organizations rely on Causaly to unlock scientific insights from external and internal information at unprecedented levels of precision and efficiency. For more information, visit causaly.com.

      Modal title

      Also from this source

      Causaly is Now Available in Microsoft Copilot

      Causaly is Now Available in Microsoft Copilot

      Causaly today announced an expansion of its collaboration with Microsoft that brings agentic scientific research directly into Microsoft Copilot....

      Causaly and Syneos Health Partner to Raise the Scientific Intensity of Clinical Research

      Causaly and Syneos Health Partner to Raise the Scientific Intensity of Clinical Research

      Causaly, the agentic AI platform purpose-built for life sciences research and development, today announced a strategic partnership with Syneos...

      More Releases From This Source

      Explore

      Biotechnology

      Biotechnology

      STEM (Science, Tech, Engineering, Math)

      STEM (Science, Tech, Engineering, Math)

      Broadcast Tech

      Broadcast Tech

      Computer & Electronics

      Computer & Electronics

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.